
GMED
Globus Medical, Inc.NYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
22.11
PEG
0.05
P/B
2.60
P/S
4.05
EV/EBITDA
14.05
DCF Value
$38.42
FCF Yield
4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.4%
Operating Margin
16.3%
Net Margin
18.3%
ROE
12.4%
ROA
17.2%
ROIC
8.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $826.4M | $140.6M | $1.01 |
| FY 2025 | $2.94B | $537.9M | $3.92 |
| Q3 2025 | $769.0M | $119.0M | $0.88 |
| Q2 2025 | $745.3M | $202.8M | $1.49 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
1.09
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.